Literature DB >> 34050453

Down-Regulation of ID2-AS1 Alleviates the Neuronal Injury Induced by 1-Methy1-4-Phenylpyridinium in Human Neuroblastoma Cell Line SH-SY5Y Cells Through Regulating miR-199a-5p/IFNAR1/JAK2/STAT1 Axis.

Furong Xu1, Hui Wang2, Ju Tian3, Haiyan Xu4.   

Abstract

We aimed to illustrate the roles and molecular mechanisms of ID2-AS1 in parkinson's disease (PD).
Methods: qRT-PCR detected the expression of ID2-AS1. CCK-8, LDH release assays the effect of ID2-AS1 knockdown on PD cells. Flow cytometry and Western Blot were used to detect the effect of ID2-AS1 inhibition on PD cell apoptosis. ELISA analysis showed that ID2-AS1 inhibition can reduce the inflammation of PD cells. ROS activity assay showed that inhibiting ID2-AS1 attenuated the oxidative stress induced by 1-methy1-4-phenylpyridinium (MPP+). RNA binding protein immunoprecipitation assay showed that ID2-AS1 is mainly located in the cytoplasm. The luciferase reporter assay is used to verify the interaction. In our study, ID2-AS1 was concentration-dependently and time-dependently up-regulated in MPP+ -treated human neuroblastoma cell line SH-SY5Y. ID2-AS1 knockdown enhanced cell proliferation and decreased cell death in PD cells. Knockdown of ID2-AS1 attenuates MPP+ -induced cytotoxicity in SH-SY5Y cells. ID2-AS1 is a sponge of miR-199a-5p. IFNAR1 is a target of miR-199a-5p. Inhibition of miR-199a-5p and overexpression of IFNAR1 alleviate the inhibitory effect of ID2-AS1 knockdown on MPP+ triggered neuronal injury. Inhibition of miR-199a-5p and overexpression of IFNAR1 alleviate the inhibitory effect of ID2-AS1 knockdown on MPP+ -triggered JAK2/STAT1 activation. Overall, down-regulation of ID2-AS1 alleviated the neuronal injury in PD through regulating miR-199a-5p/IFNAR1/JAK2/STAT1 axis.

Entities:  

Keywords:  ID2-AS1; IFNAR1; JAK2/STAT1; Neuronal injury; Parkinson’s disease; miR-199a-5p

Year:  2021        PMID: 34050453     DOI: 10.1007/s11064-021-03356-4

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  33 in total

Review 1.  The emerging role of lncRNAs in cancer.

Authors:  Maite Huarte
Journal:  Nat Med       Date:  2015-11       Impact factor: 53.440

2.  microRNA-155 Regulates Alpha-Synuclein-Induced Inflammatory Responses in Models of Parkinson Disease.

Authors:  Aaron D Thome; Ashley S Harms; Laura A Volpicelli-Daley; David G Standaert
Journal:  J Neurosci       Date:  2016-02-24       Impact factor: 6.167

Review 3.  Long noncoding RNAs and human disease.

Authors:  Orly Wapinski; Howard Y Chang
Journal:  Trends Cell Biol       Date:  2011-05-06       Impact factor: 20.808

4.  LncRNA ID2-AS1 suppresses tumor metastasis by activating the HDAC8/ID2 pathway in hepatocellular carcinoma.

Authors:  Yuqiang Zhou; Lin Huan; Yangjun Wu; Chunyang Bao; Bing Chen; Lu Wang; Shenglin Huang; Linhui Liang; Xianghuo He
Journal:  Cancer Lett       Date:  2019-11-13       Impact factor: 8.679

5.  The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation.

Authors:  Vidisha Tripathi; Jonathan D Ellis; Zhen Shen; David Y Song; Qun Pan; Andrew T Watt; Susan M Freier; C Frank Bennett; Alok Sharma; Paula A Bubulya; Benjamin J Blencowe; Supriya G Prasanth; Kannanganattu V Prasanth
Journal:  Mol Cell       Date:  2010-09-24       Impact factor: 17.970

6.  Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression.

Authors:  Ahmad M Khalil; Mitchell Guttman; Maite Huarte; Manuel Garber; Arjun Raj; Dianali Rivea Morales; Kelly Thomas; Aviva Presser; Bradley E Bernstein; Alexander van Oudenaarden; Aviv Regev; Eric S Lander; John L Rinn
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-01       Impact factor: 11.205

Review 7.  The prevalence of Parkinson's disease: a systematic review and meta-analysis.

Authors:  Tamara Pringsheim; Nathalie Jette; Alexandra Frolkis; Thomas D L Steeves
Journal:  Mov Disord       Date:  2014-06-28       Impact factor: 10.338

8.  LincRNA-p21 activates p21 in cis to promote Polycomb target gene expression and to enforce the G1/S checkpoint.

Authors:  Nadya Dimitrova; Jesse R Zamudio; Robyn M Jong; Dylan Soukup; Rebecca Resnick; Kavitha Sarma; Amanda J Ward; Arjun Raj; Jeannie T Lee; Phillip A Sharp; Tyler Jacks
Journal:  Mol Cell       Date:  2014-05-22       Impact factor: 17.970

9.  Influence of microRNA deregulation on chaperone-mediated autophagy and α-synuclein pathology in Parkinson's disease.

Authors:  L Alvarez-Erviti; Y Seow; A H V Schapira; M C Rodriguez-Oroz; J A Obeso; J M Cooper
Journal:  Cell Death Dis       Date:  2013-03-14       Impact factor: 8.469

10.  LncRNA-Hh Strengthen Cancer Stem Cells Generation in Twist-Positive Breast Cancer via Activation of Hedgehog Signaling Pathway.

Authors:  Mingli Zhou; Yixuan Hou; Guanglun Yang; Hailong Zhang; Gang Tu; Yan-e Du; Siyang Wen; Liyun Xu; Xi Tang; Shifu Tang; Li Yang; Xiaojiang Cui; Manran Liu
Journal:  Stem Cells       Date:  2015-11-17       Impact factor: 6.277

View more
  2 in total

1.  Chronic Pesticide Exposure in Farm Workers Is Associated with the Epigenetic Modulation of hsa-miR-199a-5p.

Authors:  Giuseppe Gattuso; Luca Falzone; Chiara Costa; Federica Giambò; Michele Teodoro; Silvia Vivarelli; Massimo Libra; Concettina Fenga
Journal:  Int J Environ Res Public Health       Date:  2022-06-08       Impact factor: 4.614

Review 2.  Regulation of Hypoxic Signaling and Oxidative Stress via the MicroRNA-SIRT2 Axis and Its Relationship with Aging-Related Diseases.

Authors:  Taku Kaitsuka; Masayuki Matsushita; Nobuko Matsushita
Journal:  Cells       Date:  2021-11-26       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.